Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting

被引：0
|
作者：
René J. Boosman
Merel Jebbink
Wouter B. Veldhuis
Stefanie L. Groenland
Bianca A. M. H. van Veggel
Pim Moeskops
Adrianus J. de Langen
Jos H. Beijnen
Egbert F. Smit
Alwin D. R. Huitema
Neeltje Steeghs
机构：
[1] The Netherlands Cancer Institute - Antoni Van Leeuwenhoek,Department of Pharmacy & Pharmacology
[2] The Netherlands Cancer Institute - Antoni Van Leeuwenhoek,Department of Thoracic Oncology
[3] University Medical Center Utrecht,Department of Radiology
[4] Utrecht University,Department of Medical Oncology and Clinical Pharmacology
[5] The Netherlands Cancer Institute - Antoni Van Leeuwenhoek,Department of Pharmaceutical Sciences
[6] Utrecht University,Department of Clinical Pharmacy
[7] Department of Pharmacology Princess Máxima Center for Pediatric Oncology,undefined
[8] University Medical Center Utrecht,undefined
[9] Utrecht University,undefined
来源：
Pharmaceutical Research | 2022年 / 39卷
关键词：
exposure–response analysis; NSCLC; osimertinib; pharmacokinetics-pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2507 / 2514
页数：7
相关论文
共 50 条
  • [1] Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting
    Boosman, Rene J.
    Jebbink, Merel
    Veldhuis, Wouter B.
    Groenland, Stefanie L.
    van Veggel, Bianca A. M. H.
    Moeskops, Pim
    de Langen, Adrianus J.
    Beijnen, Jos H.
    Smit, Egbert F.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    PHARMACEUTICAL RESEARCH, 2022, 39 (10) : 2507 - 2514
  • [2] Osimertinib for the treatment of patients with EGFR mutation-positive non-small cell lung cancer
    Alsharedi, M.
    Bukamur, H.
    Elhamdani, A.
    DRUGS OF TODAY, 2018, 54 (06) : 369 - 379
  • [3] Osimertinib for treating Patients with EGFR Mutation-Positive non-small cell Lung Cancer
    Meinrenken, Susanne
    PNEUMOLOGIE, 2018, 72 (04): : 246 - 246
  • [4] Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer
    van Veggel, B.
    Santos, J. F. Vilacha Madeira R.
    Hashemi, S. M. S.
    Paats, M. S.
    Monkhorst, K.
    Heideman, D. A. M.
    Groves, M.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    van der Wekken, A. J.
    de Langen, A. J.
    LUNG CANCER, 2020, 141 : 9 - 13
  • [5] Real-Life Data of Osimertinib in Pretreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR T790M Mutation
    Alfaro Autor, C.
    Romero, A.
    Calvo De Juan, V.
    Franco, F.
    Sanchez Romero, E.
    Ortiz Cortes, N.
    Sanz Moreno, S.
    Rodriguez Festa, A.
    Serna Blasco, R.
    Barquin Del Romo, M.
    Provencio, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1036 - S1036
  • [6] Real-life efficacy of osimertinib in pretreated patients with advanced non-small cell lung cancer harboring EGFR T790M mutation
    Auliac, Jean Bernard
    Perol, Maurice
    Planchard, David
    Monnet, Isabelle
    Wislez, Marie
    Doubre, Helene
    Guisier, Florian
    Pichon, Eric
    Greillier, Laurent
    Mastroianni, Benedicte
    Decroisette, Chantal
    Schott, Roland
    Le Moulec, Sylvestre
    Arrondeau, Jennifer
    Cortot, Alexis B.
    Geriniere, Laurence
    Renault, Aldo
    Daniel, Catherine
    Falchero, Lionel
    Chouaid, Christos
    LUNG CANCER, 2019, 127 : 96 - 102
  • [7] Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC)
    Paulina Bracht, Jillian Wilhelmina
    Karachaliou, Niki
    Berenguer, Jordi
    Pedraz-Valdunciel, Carlos
    Filipska, Martyna
    Codony-Servat, Carles
    Codony-Servat, Jordi
    Rosell, Rafael
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (12): : 2607 - 2614
  • [8] Comment on: 'Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer'
    Inagaki, Yuji
    Tamiya, Akihiro
    LUNG CANCER, 2020, 148 : 179 - 180
  • [9] Non small cell lung cancer patients with EGFR mutation : therapeutic sequences in a real life setting
    Berardi, G.
    Girard, N.
    De Fraipont, F.
    Decroisette, C.
    Gazzerie, S.
    Sibilot, D. Moro
    Toffart, A. C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [10] Efficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion
    Kiritani, Ayu
    Amino, Yoshiaki
    Uchibori, Ken
    Akita, Takahiro
    Harutani, Yuhei
    Ogusu, Shinsuke
    Tsugitomi, Ryosuke
    Manabe, Ryo
    Ariyasu, Ryo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    THORACIC CANCER, 2024, 15 (05) : 402 - 409
12345